Clinical Trials

The work presented here illustrates how Differential Scanning Calorimetry (DSC) is used in the early stages of protein characterization to rapidly provide critical data about protein stability that can be used as a guide to support and accelerate liquid formulation.

A clinical trial of an FAAH inhibitor in France goes terribly wrong, but whether the compound or manufacturing are to blame remains to be seen

How do we move on from a sombre start to 2016?

See how thermodynamics can be used to improve your lead optimization process.

Advanced digital technologies are sweeping through the world and changing the way we live our lives and do business.

This application note describes how and when can kinetic information be retrieved from ITC power curves.

Clinical development is outmoded; we are witnessing serious attrition in cancer R&D. Perhaps it’s time to live and die by the mantra: “no biomarker, no trial”.

Despite clinical failures in the 1990s, pharma is (cautiously) ready to try again with oral peptide formulations.

Drug makers and regulators are taking steps towards transparency, but is it enough?

It is well established that the use of nanotechnology in medicine and more specifically drug delivery is spreading rapidly.